ArticleScientific reports2025
A new 13-lipoxygenase from Taxus media callus is functionally linked to paclitaxel biosynthesis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The GhWRKY70-International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The enzyme 13-Lipoxygenase (13-LOX) plays a pivotal role in the biosynthesis of jasmonates. While Taxus sp. cell suspension cultures have displayed the crucial involvement of Jasmonic acid (JA) in paclitaxel (PTX) biosynthesis activation, 13-LOX had not been identified in this plant species. In this work, a complete cDNA, encoding an 891-amino acid protein sharing high identity with other plant 13-LOXs, was identified (NCBI Genbank MW030627). The purified recombinant TmLOX13 demonstrated optimal enzymatic activity at pH 6.5 and 45 °C, displaying a strong specificity for α-linolenic acid (C18:3) and regioselectivity for carbon 13, producing 13-Hydroperoxyoctadeca-9,11,15-trienoic acid (13-HPOT). Furthermore, TmLOX13 expression in T. media cell suspension cultures peaked before the PTX production phase, suggesting a potential biological link between the 13-LOX pathway and PTX biosynthesis. This connection was validated through a small interference RNA (siRNA)-silencing approach, where silencing of TmLOX13 in T. media cells led to a significant deficiency in PTX biosynthesis, accompanied by a marked down-regulation of PTX gene expression. Similar effects were observed when the 13-LOX activity was inhibited using nordihydroguaiaretic acid (NDGA), a specific inhibitor of 13-LOX. Of particular interest, the PTX-deficient phenotype of TmLOX13-silenced cells was effectively rescued by exogenous supplementation with oxylipins derived from the 13-LOX-peroxygenase pathway. This comprehensive investigation sheds light on the functional significance of TmLOX13 in the intricate network of biochemical pathways underlying PTX biosynthesis in Taxus media.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.